🔥 Recommendations for Implementing #HepatitisC Virus Care in Homeless Shelters: The Stakeholder Perspective Read here 👉 ow.ly/m5S650IG4LP #livertwitter #VisualAbstract #openaccess AASLD

New 📃 looks at the association of body composition with outcomes after liver resection for #cholangiocarcinoma   #SarcopenicObesity may impact survival in patients with iCCA doi.org/10.1002/hep4.2… #LiverTwitter #OpenAccess #VisualAbstract

3. I hope to never see again in a grant or paper review another comment about patients with cirrhosis not being tech savvy or that electronic interventions won’t work in “these patients”. journals.lww.com/ajg/abstract/9…

I love this work by my dear friend Jeremy Louissaint! We need to think about ways to mitigate the potential psychological harms of immediate release of abnormal results, especially cancer diagnoses! I wonder if #LLMs can help 🤔

Congratulations Dr. Louissaint and team on this important study!

With some of my amazing co-fellows at FOCUS GI San Antonio. A lifetime of learning. Thanks to all the speakers who volunteered their time and tutelage. And a big thanks to the leadership at UTSW Gastroenterology Fellowship for allowing this opportunity.

ALL RISE! ORDER IN THE COURT! We now present the debate of whether you believe satellite clinics improve access to liver transplant or do not P.S. Keep reading for 2 amazing articles to explain why/why not #livertwitter

Important innovative work on the shift of result-related patient-provider communication Jeremy Louissaint UT Southwestern Medical Center is just getting warmed up. Much more to come 👏🏻 👏🏻

And for our current leaders📢 – AGA Leadership Summit & Advocacy Day is where decisions + progress + fun happen and you don't want to miss it! Check your email for details – registration deadline is tomorrow 8/14❗️#MariasMusings

#Blackwomeninmedicine- dont forget to register for The NEXUS Conference. Join us in NYC September 27-29 for an incredible line-up of events and speakers. Register here 👉🏾 bit.ly/ABGHNEXUS24reg… See you there! ABGH

📑 Noninvasive predictors of clinically significant portal hypertension in #NASH cirrhosis❗️ 1️⃣ANTICIPATE (TE+Plt) & ANTICIPATE-NASH (+BMI) predict CSPH 2️⃣New model, ⭐️ FIB4+ (FIB4+Albumin), also predicts CSPH and does not require elastography❕ journals.lww.com/hepcomm/fullte…

According to data 📈 from Liver International: 🌟stretching 🌟meditation reduced #cramp severity and improved quality of life among patients with #cirrhosis. Elliot Tapper weighed in ⚖ at the 🔗 below 🔽 healio.com/news/gastroent…

📑 Predicting NAFLD prevalence in the US using NHANES elastography data and applying 🤖 learning❗️ 1️⃣High prevalence of #NAFLD (25.3%) 2️⃣Prevalence ⬆️ w T2DM (54.6%)❕ 3️⃣Machine Learning models w AUC 0.79-0.84 journals.lww.com/hepcomm/fullte…

Congratulations Ashley Spann on this incredible review! #Informatics #LiverTransplant #LiverTwitter

Must read article on population screening for #cirrhosis from leader of the field, THE Maja Thiele Open access journals.lww.com/hepcomm/fullte…

Mirror mirror on the wall Which of these risk scores is fairest of all LiverRisk SAFE APRI FIB-4 Three databases. One study. In Hepatology Communications journals.lww.com/hepcomm/fullte…

📑 #NASH is the most common indication for LT among the elderly❗️ 1️⃣ Proportion of LT occurring in patients age 65+ years 📈 2️⃣ NASH etiology in more than 1 in 3 listings with ⬆️ prevalence over time #LiverTwitter #MASLD #OpenAccess journals.lww.com/hepcomm/fullte…

Informatics driven solutions for optimal care delivery in Liver Transplantation. Written by 3 absolute bosses - Ashley Spann, Jeremy Louissaint, and Manhal Izzy. journals.lww.com/lt/abstract/99…

📑 GATA4 downregulation enhances CCL20-mediated immunosuppression in #HCC❗️ ⭐️ GATA4-low tumors promote immunosuppression via CCL20-driven enrichment of Tregs and MDSCs❕ journals.lww.com/hepcomm/fullte…

🔷 Let's discuss current and future therapies for autoimmune #hepatitis: Hepatology Communications journals.lww.com/hepcomm/fullte… #livertwitter #GITwitter #MedTwitter RUSH Internal Medicine